DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Death receptor 5
Death receptor 5
The TNF and TNF Receptor Review Superfamilies: Integrating Mammalian Biology
Download
Activating Death Receptor DR5 As a Therapeutic Strategy for Rhabdomyosarcoma
Ligand–Receptor Binding Revealed by the TNF Family Member TALL-1
TRAIL and Cardiovascular Disease—A Risk Factor Or Risk Marker: a Systematic Review
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure: the HOMAGE Study
On the TRAIL of Better Therapies: Understanding TNFRSF Structure-Function
Biolegend.Com
Targeting TRAIL-Rs in KRAS-Driven Cancer Silvia Von Karstedt 1,2,3 and Henning Walczak2,4,5
Cell Structure & Function
Death Receptor 5, a New Member of the TNFR Family, and DR4 Induce FADD-Dependent Apoptosis and Activate the NF-B Pathway
Inflammatory Cytokine Regulation of Death Receptor
Apo2l/TRAIL and Its Death and Decoy Receptors
BAFF Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell Population
Human Cancers Express Trailshort, a Dominant Negative TRAIL Splice
Exploiting the Extrinsic and the Intrinsic Apoptotic Pathways for Cancer Therapeutics
Apoptotic and Antitumor Activity of Death Receptor Antibodies Require Inhibitory Fcγ Receptor Engagement
Innovation Driven Outcomes Focused September 2020 Presentation Disclaimer
Top View
Peptide Phage Display As a Tool for Drug Discovery: Targeting Membrane Receptors
Luteolin Induces Apoptosis Via Death Receptor 5 Upregulation in Human Malignant Tumor Cells
The Tumor Necrosis Factor Family: Family Conventions and Private Idiosyncrasies
WO 2015/017822 Al 5 February 2015 (05.02.2015) P O P C T
Death Receptor Agonists As a Targeted Therapy for Cancer
Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer
Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy
Signal Transduction by Tumour Necrosis Factor and Tumour Necrosis Factor Related Ligands and Their Receptors
16 Expression and Regulation of Death Receptors in Multiple Myeloma and Prostate Carcinoma
Prostaglandin J2 Induces Death Receptor 5 Expression Through Mrna Stabilization Independently Ofppar ; and Potentiates TRAIL-Induced Apoptosis
Prognostic Significance of Serum Soluble DR5 Levels in Small-Cell Lung Cancer Zhenfa Wan1,#, Xiaoshan Zhang2,#, Xinshuang Yu3, Yong Hou3,
Potentiation of Fas-Mediated Apoptosis by an Engineered Glycosylphosphatidylinositol-Linked Fas
1 Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy
New Insights Into Apoptosis Signaling by Apo2l/TRAIL
CD70-Restricted Specific Activation of TRAILR1 Or
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
Death Receptor 5 (TNFRSF10B)
Confirming a Critical Role for Death Receptor 5 and Caspase-8 In
Catalytic Receptors
Challenges for Immunotherapy in Multiple Myeloma: Bone Marrow Microenvironment-Mediated Immune Suppression and Immune Resistance
61 1. ABSTRACT 2. INTRODUCTION the Emerging Role of CD30 And
CD70-Restricted Specific Activation of TRAILR1 Or
Gene Expression in Human Endothelial Cells TRAIL Induces
DR5) Contribute Differently to TRAIL-Mediated Apoptosis
Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling
Agonists of the TRAIL Death Receptor DR5 Sensitize Intestinal Stem Cells
A Review of Bispecific Antibodies and Antibody Constructs in Oncology And
Role of TRAIL-Receptors in Apoptosis and Nonapoptotic Signaling in Cancer Cells Populations Undergoing Fractional Killing Yelyzaveta Shlyakhtina
Molecular Mode of Action of TRAIL Receptor Agonists—Common Principles and Their Translational Exploitation
Improving Combination Cancer Immunotherapy with a Novel, Dual-Specific Immunotherapeutic Platform That Links T Cell Costimulatory Pathways
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure: the HOMAGE Study
Synthetic Ligands of Death Receptor 5 Display a Cell-Selective Agonistic Effect at Different Oligomerization Levels
The Crystal Structure of the Costimulatory OX40-OX40L Complex
Implication of NF-Κb and P53 in the Expression of TRAIL-Death
194.Full.Pdf
WO 2018/056821 Al 29 March 2018 (29.03.2018) W !P O PCT
YIPF2 Promotes Chemotherapeutic Agent-Mediated Apoptosis Via
Deciphering the Role of the Death Receptor Fas/CD95 in T Cell Co-Stimulation Giorgia Miloro
Therapeutic Expression of an Anti-Death Receptor 5 Single-Chain Fixed-Variable Region Prevents Tumor Growth in Mice
Enhancing the Antitumor Efficacy of a Cell-Surface Death Ligand by Covalent Membrane Display
CPC Notice of Changes 234-DP0077 (C07K)
Data Sheet Immunotools Excellent Quality
BAFF Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell Population